140 related articles for article (PubMed ID: 36934589)
1. The synergistic effect of chimeras consisting of N-terminal smac and modified KLA peptides in inducing apoptosis in breast cancer cell lines.
Tavakoli S; Firoozpour L; Davoodi J
Biochem Biophys Res Commun; 2023 May; 655():138-144. PubMed ID: 36934589
[TBL] [Abstract][Full Text] [Related]
2. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
3. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
[TBL] [Abstract][Full Text] [Related]
4. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
[TBL] [Abstract][Full Text] [Related]
6. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
Fandy TE; Shankar S; Srivastava RK
Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ.
Arnt CR; Chiorean MV; Heldebrant MP; Gores GJ; Kaufmann SH
J Biol Chem; 2002 Nov; 277(46):44236-43. PubMed ID: 12218061
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS
J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416
[TBL] [Abstract][Full Text] [Related]
10. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
11. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
12. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo.
Gao Z; Tian Y; Wang J; Yin Q; Wu H; Li YM; Jiang X
J Biol Chem; 2007 Oct; 282(42):30718-27. PubMed ID: 17724022
[TBL] [Abstract][Full Text] [Related]
13. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
14. Monomerization of cytosolic mature smac attenuates interaction with IAPs and potentiation of caspase activation.
Burke SP; Smith JB
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957035
[TBL] [Abstract][Full Text] [Related]
15. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.
Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F
Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines.
Mizukawa K; Kawamura A; Sasayama T; Tanaka K; Kamei M; Sasaki M; Kohmura E
J Neurooncol; 2006 May; 77(3):247-55. PubMed ID: 16575541
[TBL] [Abstract][Full Text] [Related]
17. Smac/DIABLO and colon cancer.
Anguiano-Hernandez YM; Chartier A; Huerta S
Anticancer Agents Med Chem; 2007 Jul; 7(4):467-73. PubMed ID: 17630921
[TBL] [Abstract][Full Text] [Related]
18. Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy.
Zhao XY; Wang XY; Wei QY; Xu YM; Lau ATY
Cells; 2020 Apr; 9(4):. PubMed ID: 32325691
[TBL] [Abstract][Full Text] [Related]
19. Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death.
Hui KK; Kanungo AK; Elia AJ; Henderson JT
Cell Death Differ; 2011 Nov; 18(11):1780-90. PubMed ID: 21597464
[TBL] [Abstract][Full Text] [Related]
20. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
